Insiders Dyne Therapeutics, Inc.

Stocks

DYN

US26818M1080

Biotechnology & Medical Research

Real-time Estimate Cboe BZX Other stock markets 12:06:19 2026-06-11 pm EDT			5-day change	1st Jan Change
17.92 ^USD	+1.44%		-3.31%	-9.00%

Jun. 03	Dyne Therapeutics, Inc. Announces Completion of Enrollment in Registrational Expansion Cohort of ACHIEVE Trial of Z-Basivarsen for Myotonic Dystrophy Type 1	CI
May. 26	Dyne Therapeutics Submits Biologics License Application to U.S. FDA For Z-Rostudirsen In Exon 51 Duchenne Muscular Dystrophy	CI

Insiders

Apr. 28	Dyne Therapeutics Insider Sold Shares Worth $7,101,120, According to a Recent SEC Filing	MT
Apr. 23	Dyne Therapeutics Insider Sold Shares Worth $16,477,388, According to a Recent SEC Filing	MT
Mar. 13	Dyne Therapeutics Insider Sold Shares Worth $2,530,562, According to a Recent SEC Filing	MT
Dec. 23	Dyne Therapeutics, Inc. Announces the Appointment of Vikram Karnani to Its Board of Directors	CI
Dec. 23	Dyne Therapeutics appoints Vikram Karnani to board of directors	RE
25-10-02	Dyne Therapeutics, Inc. Appoints Brian Posner to Its Board of Directors	CI
25-07-16	Dyne Therapeutics Shares Rise After CEO Stock Purchase Disclosure	MT
25-07-15	Dyne Therapeutics Insider Bought Shares Worth $911,000, According to a Recent SEC Filing	MT
25-04-15	Dyne Therapeutics, Inc. Announces Management Changes	CI
25-03-20	Dyne Therapeutics Names Erick Lucera as CFO	MT
25-03-20	Dyne Therapeutics Announces Appointment of Erick J. Lucera As Chief Financial Officer	RE
25-03-20	Dyne Therapeutics, Inc. Announces Executive Changes	CI
24-09-19	Dyne Therapeutics Insider Sold Shares Worth $308,864, According to a Recent SEC Filing	MT
24-09-04	Dyne Therapeutics Insider Bought Shares Worth $1,057,216, According to a Recent SEC Filing	MT
24-09-03	Dyne Therapeutics, Inc Announces Management Changes	CI
24-06-25	Dyne Therapeutics Insider Sold Shares Worth $1,401,902, According to a Recent SEC Filing	MT
24-06-14	Dyne Therapeutics Insider Sold Shares Worth $1,334,201, According to a Recent SEC Filing	MT
24-06-12	Dyne Therapeutics Insider Sold Shares Worth $2,583,782, According to a Recent SEC Filing	MT
24-05-23	Dyne Therapeutics Insider Sold Shares Worth $1,002,751, According to a Recent SEC Filing	MT
24-03-25	Dyne Therapeutics President, CEO Joshua Brumm Resigns, John Cox Named Successor; Shares Drop 7% Pre-Bell	MT
24-03-25	Dyne Therapeutics, Inc. Announces Management Changes	CI
24-03-25	Dyne Therapeutics, Inc. Announces Chief Executive Officer Changes	CI
24-03-05	Dyne Therapeutics Insider Sold Shares Worth $1,398,347, According to a Recent SEC Filing	MT
24-03-04	Dyne Therapeutics Insider Sold Shares Worth $2,895,519, According to a Recent SEC Filing	MT
24-03-04	Dyne Therapeutics Insider Sold Shares Worth $811,865, According to a Recent SEC Filing	MT